These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9280338)

  • 1. Gamma radiation does not prevent transfusion-induced HLA alloimmunization.
    Ohto H
    Transfusion; 1997 Aug; 37(8):878-9. PubMed ID: 9280338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
    Kuntz BM; Wollenhaupt HJ; Brüster HT
    Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alloimmunization in poly-transfused patients with hemoglobin S disease].
    Gómez Oliva P; Basanta Otero P; González Villalonga C; Batista Veranes M; Orbeal Aldama L; García Echevarría M
    Sangre (Barc); 1985; 30(4-A):406-10. PubMed ID: 4071354
    [No Abstract]   [Full Text] [Related]  

  • 4. Class I HLA molecules on human erythrocytes. Quantitation and transfusion effects.
    Everett ET; Kao KJ; Scornik JC
    Transplantation; 1987 Jul; 44(1):123-9. PubMed ID: 3603672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of a secondary human anti-HLA alloimmune response in severe combined immunodeficient mice engrafted with human lymphocytes.
    Lazarus AH; Crow AR; Semple JW; Cosgrave D; Kalovsky EJ; Hannach B; Blanchette V; Freedman J
    Transfusion; 1997; 37(11-12):1192-9. PubMed ID: 9426645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of severe thrombocytopenia in alloimmunized, transfusion-refractory patients.
    Ornstein DL; Mortara KL; Smith MB; Ririe DW; Shaughnessy PJ; Bickford DJ; Kissack BL
    Mil Med; 2001 Mar; 166(3):269-74. PubMed ID: 11263033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
    Amemiya Y
    Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of the nonhemolytic type of reactions during the transfusion of blood and its components].
    Zaĭtseva GA; Zheleznova AI; Moiseeva VG; Aribzhanova IM; Vozgegova NP
    Gematol Transfuziol; 1984 Mar; 29(3):24-7. PubMed ID: 6714625
    [No Abstract]   [Full Text] [Related]  

  • 9. [Strategies for prevention of adverse transfusion effects. Immediate and delayed transfusion effects: laboratory reference for transfusion reactions].
    Kiyokawa H
    Rinsho Byori; 1991 Mar; Suppl 88():128-37. PubMed ID: 1856964
    [No Abstract]   [Full Text] [Related]  

  • 10. Do HLA antibodies cause hemolytic transfusion reactions or decreased RBC survival?
    Nance ST
    Transfusion; 2003 Jun; 43(6):687-90. PubMed ID: 12757516
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute and delayed hemolytic transfusion reactions secondary to HLA alloimmunization.
    Benson K; Agosti SJ; Latoni-Benedetti GE; Leparc GF
    Transfusion; 2003 Jun; 43(6):753-7. PubMed ID: 12757526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transfusional alloimmunization].
    Gausset P
    Rev Med Brux; 1989 Apr; 10(4):132-7. PubMed ID: 2664962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation.
    Snyder EL
    Yale J Biol Med; 1990; 63(5):419-27. PubMed ID: 2293501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell alloimmunization: lessons from sickle cell disease.
    Treml A; King KE
    Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994
    [No Abstract]   [Full Text] [Related]  

  • 15. Red Blood Cell Antibodies in Hematology/Oncology Patients: Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies.
    Hendrickson JE; Tormey CA
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):635-51. PubMed ID: 27113001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation and management of platelet refractoriness and alloimmunization.
    Delaflor-Weiss E; Mintz PD
    Transfus Med Rev; 2000 Apr; 14(2):180-96. PubMed ID: 10782501
    [No Abstract]   [Full Text] [Related]  

  • 17. Understanding red blood cell alloimmunization triggers.
    Hendrickson JE; Tormey CA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):446-451. PubMed ID: 27913514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of blood groups in surgical practice].
    Dutkevich IG; Golovin GV
    Vestn Khir Im I I Grek; 1989 Jun; 142(6):92-5. PubMed ID: 2510392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alloimmunization and transfusion refractoriness to thrombocyte substitution].
    Söhngen D; Schneider W
    Klin Wochenschr; 1991 Jul; 69(10):419-25. PubMed ID: 1942953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complications associated with chronic transfusion.
    Harris DJ
    J Infus Nurs; 2002; 25(5):316-9. PubMed ID: 12355057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.